Order Synvisc® Classic for Clinics

Synvisc® Classic is a sterile intra-articular viscosupplement containing hylan G-F 20 for professional knee injection workflows. Licensed clinics and healthcare professionals can order Synvisc Classic 2 mL prefilled syringes for use in osteoarthritis care pathways, procedure rooms, and image-guided injection services. Each carton contains three single-use prefilled syringes, with each syringe providing Synvisc Classic 16 mg/2 mL.

This product is intended for administration by qualified professionals using strict aseptic technique. It fits established nonoperative knee osteoarthritis protocols where clinicians use viscosupplementation to supplement the viscoelastic properties of synovial fluid. Med Wholesale Supplies supports clinic procurement with brand-name products sourced through vetted distributors, US distribution, and professional documentation for receiving and lot tracking.

Synvisc Classic 2 mL Price and Clinic Ordering

Sign in to a verified business account to view the current Synvisc Classic price for your clinic. Pricing may reflect account status, contract tiers, volume needs, and purchasing configuration, but exact cost should be confirmed during ordering. Clinics that run recurring injection sessions can save the SKU to purchasing lists for faster replenishment.

Synvisc Classic is supplied as a three-syringe carton for clinical inventory planning. The 2 mL prefilled syringe format helps staff prepare procedure rooms consistently, document lot and expiration data, and align case loads with available stock. For broader category planning, facilities can browse orthopedic injections and coordinate related musculoskeletal products through their purchasing workflow.

Quick tip: Match carton quantities to scheduled injection series, provider availability, and internal receiving cutoffs before confirming an order.

Professional Use in Knee Osteoarthritis Care

Synvisc Classic is used as a viscosupplement for pain associated with osteoarthritis of the knee in appropriate clinical settings. Hylan G-F 20 is a cross-linked hyaluronan derivative designed to help supplement synovial fluid viscosity and elasticity. In practice, clinicians may incorporate a Hylan G-F 20 injection into a broader nonoperative plan that can also include activity modification, bracing, physical therapy, oral or topical therapies, and follow-up assessment.

Administration is intra-articular, meaning the product is injected into the joint space. Orthopedic, sports medicine, rheumatology, and interventional pain teams may perform the procedure using landmark technique, ultrasound guidance, or fluoroscopic guidance according to local protocol and training. For additional clinical background on this line, see the Synvisc Classic research summary.

Patient selection remains a clinical responsibility. The product should not be injected into an infected joint or through skin with active infection at the intended site. Intake and consent processes should also address known hypersensitivity concerns, including avian protein sensitivity, because the hylan G-F 20 line is derived from avian sources.

Composition, Strength, and Carton Configuration

The active component is hylan G-F 20, a cross-linked derivative of hyaluronan formulated in a sterile, buffered aqueous vehicle for intra-articular use. The carton contains three prefilled syringes. Each syringe provides 2 mL, corresponding to Synvisc Classic 16 mg/2 mL. Item SKU: 82248.

Clear carton and unit labeling supports lot capture, expiration tracking, and inventory rotation. Staff should inspect the sterile barrier during procedure setup and should not use a syringe if packaging integrity is compromised.

Clinic Workflow and Treatment-Room Fit

Prefilled syringes reduce preparation steps and help standardize setup across providers and locations. Procedure teams can build trays around local requirements for skin preparation, draping, anesthetic use when applicable, guidance equipment, sharps handling, and documentation. The single-use design supports aseptic technique and reduces point-of-care manipulation compared with formats that require additional drawing-up steps.

Synvisc Classic prefilled syringe 2 mL can be integrated into outpatient procedure blocks. Predictable presentation helps coordinators estimate room turnover, staff assignments, and supply needs for multi-patient sessions. Clinics that stock multiple viscosupplement brands can separate cartons by product, lot, and expiration date to reduce selection errors during busy schedules.

Rheumatology and orthopedic services can also coordinate adjacent stocking through rheumatology and medical devices categories when building procedure-room supply lists.

Storage, Handling, and Receiving Checks

Store and handle Synvisc Classic as directed on the manufacturer label and according to facility policy. Receiving staff should verify product identity, carton count, lot number, and expiration date before releasing inventory to clinical storage. Documentation accompanying each shipment can support receiving checks and traceability within your inventory system.

Shipping is coordinated with temperature-controlled handling when required and tracked US delivery. Clinics should move products into appropriate storage promptly after receipt and keep the product in its original packaging until procedure preparation. Do not use any unit if the sterile barrier, labeling, or syringe presentation appears damaged.

Before a procedure session, confirm that staff have the correct syringe count, appropriate injection supplies, and the patient-specific documentation required under local policy. This is especially important for multi-provider clinics where similar hyaluronic acid products may be stocked together.

Safety, Contraindications, and Monitoring

Synvisc Classic should be administered only by trained healthcare professionals. Avoid use in the presence of active joint infection, skin disease, or infection at the injection site. Screen for known hypersensitivity to avian proteins, feathers, or egg products as part of the clinic’s intake process, and follow the manufacturer’s professional labeling for contraindications and precautions.

Local post-injection reactions can occur. These may include pain, swelling, warmth, stiffness, or fluid accumulation around the treated joint. Clinics should provide post-procedure instructions consistent with their protocol, including guidance on when patients should contact the office for worsening pain, marked swelling, fever, rash, or other concerning symptoms.

Post-procedure guidance often includes a brief limitation of strenuous or high-impact activity according to clinic policy. The patient’s overall osteoarthritis plan, response history, imaging, comorbidities, and concurrent therapies should guide follow-up. For a broader discussion of severe knee osteoarthritis considerations, see Synvisc and bone-on-bone osteoarthritis.

How Synvisc Classic Compares with Related Viscosupplements

Clinics often compare Synvisc Classic with other hyaluronic acid or hylan-based injections by dosing schedule, carton configuration, syringe volume, handling preferences, and formulary requirements. Synvisc Classic is the multi-syringe format in this line, while Synvisc-One is commonly evaluated when a single-injection approach is preferred.

Other viscosupplement choices may fit different clinic protocols or purchasing criteria. Facilities that maintain more than one product may also evaluate Monovisc, Hyalgan, or other options based on clinician preference and patient-specific considerations. For structured comparisons, review Synvisc versus Synvisc-One and Monovisc versus Synvisc.

Selection should not rely on brand name alone. Injection schedule, product composition, prior response, contraindications, documentation requirements, and inventory controls all affect how a viscosupplement fits a clinic’s care pathway.

Inventory Planning and Substitutions

Plan procurement before scheduled injection series or high-volume procedure days. Because viscosupplement use is often tied to appointment blocks, delayed ordering can disrupt staffing, room use, and follow-up timing. Maintaining par levels by product and provider can help teams avoid last-minute substitutions.

If a substitution is needed, confirm product differences before use. Important distinctions may include active material, syringe volume, injection schedule, packaging, labeling, and clinic protocol requirements. The Synvisc brand category can help teams keep related hylan G-F 20 products organized during replenishment.

Lot number, expiration date, receiving date, storage location, and procedure documentation should remain linked in the clinic record. This supports traceability and helps purchasing teams rotate stock appropriately.

Authoritative Sources

• Manufacturer professional prescribing information for SYNVISC
• FDA premarket approval database for medical devices
• AAOS osteoarthritis of the knee clinical guidance

This content is for informational purposes only and is not a substitute for professional medical advice.